Aura Biosciences, Inc. (NASDAQ:AURA) Receives $22.75 Average Price Target from Brokerages

Aura Biosciences, Inc. (NASDAQ:AURA – Get Free Report) has received a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy r…

Read Full Article →